PLIANT THERAPEUTICS INC (PLRX)
US7291391057 - Common Stock
ChartMill assigns a Buy % Consensus number of 86% to PLRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 42.37. This target is 258.45% above the current price.
PLRX was analyzed by 20 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about PLRX.
In the previous month the buy percentage consensus was at a similar level.
PLRX was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-10 | Needham | Reiterate | Buy -> Buy |
| 2024-03-12 | Needham | Reiterate | Buy -> Buy |
| 2024-03-05 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-28 | Needham | Reiterate | Buy -> Buy |
| 2024-02-28 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-05 | Needham | Maintains | Buy -> Buy |
| 2024-02-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-10 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-10-04 | Needham | Reiterate | Buy -> Buy |
| 2023-09-27 | Needham | Reiterate | Buy -> Buy |
| 2023-09-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-09-15 | Needham | Reiterate | Buy -> Buy |
| 2023-08-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-10 | Needham | Reiterate | Buy -> Buy |
| 2023-08-10 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-08-10 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-08-10 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-08-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-08 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-05-25 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-05-18 | Canaccord Genuity | Initiate | Buy |
| 2023-05-10 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-05-10 | RBC Capital | Maintains | Outperform |
| 2023-05-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-02 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-05-01 | Cantor Fitzgerald | Maintains | Overweight |
| 2023-05-01 | HC Wainwright & Co. | Maintains | Buy |
| 2023-04-20 | Needham | Reiterate | Buy |